FORTRESS BIOTECH INC (FBIO:NASDAQ)
$2.81 -0.02 (-0.7067%)
Analysed FORTRESS BIOTECH INC (FBIO:NASDAQ) News Sources
Journey Medical Corporation Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
12-08-2026
yahoo.com
Fortress Biotech, Inc. Q2 2026 Earnings Call Summary
14-08-2026
moby.co
Journey Medical (DERM) Stock Draws Fresh Price Target Split After Fortress Valuation Changes
25-06-2026
yahoo.com
Fortress Biotech Reports 2025 Financial Results and Recent Corporate Highlights
31-03-2026
yahoo.com
Fortress Biotech’s Subsidiary Cyprium Therapeutics Closes Sale of Rare Pediatric Disease Priority Review Voucher for $205 Million
30-03-2026
yahoo.com
Fortress Biotech to Participate in the H.C. Wainwright 2nd Annual Royalty Company Virtual Conference
04-05-2026
yahoo.com
Fortress Biotech and Subsidiary Urica Therapeutics Announce Crystalys Therapeutics’ $130 Million Series B Financing
27-07-2026
yahoo.com
Fortress Biotech Q2 Earnings Call Highlights
12-08-2026
marketbeat.com
Fortress Biotech Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
13-08-2026
yahoo.com
Fortress Biotech (FBIO) Q2 2026 Earnings Call Transcript
14-08-2026
fool.com
What is the current price of FORTRESS BIOTECH INC (FBIO:NASDAQ)?
The current price of FORTRESS BIOTECH INC (FBIO:NASDAQ) is $2.81.
FORTRESS BIOTECH INC (FBIO:NASDAQ) absolute price change since previous trading day?
The absolute price change of FORTRESS BIOTECH INC (FBIO:NASDAQ) since the previous trading day is $-0.02.
FORTRESS BIOTECH INC (FBIO:NASDAQ) percentage price change since previous trading day?
The percentage price change of FORTRESS BIOTECH INC (FBIO:NASDAQ) since the previous trading day is -0.7067%.
What is the most recent average sentiment score for FORTRESS BIOTECH INC (FBIO:NASDAQ)?
The most recent average sentiment score for FORTRESS BIOTECH INC (FBIO:NASDAQ) is 83 out of 100.
What is the most recent average sentiment for FORTRESS BIOTECH INC (FBIO:NASDAQ)?
The most recent sentiment for FORTRESS BIOTECH INC (FBIO:NASDAQ) is .
SEC-8K** Filing Available For FORTRESS BIOTECH INC (FBIO:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.